Cargando…

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

BACKGROUND: The pathological complete response (pCR) after neoadjuvant chemotherapy is a surrogate marker for a favorable prognosis in breast cancer patients. Factors capable of predicting a pCR, such as the proliferation marker Ki67, may therefore help improve our understanding of the drug response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fasching, Peter A, Heusinger, Katharina, Haeberle, Lothar, Niklos, Melitta, Hein, Alexander, Bayer, Christian M, Rauh, Claudia, Schulz-Wendtland, Ruediger, Bani, Mayada R, Schrauder, Michael, Kahmann, Laura, Lux, Michael P, Strehl, Johanna D, Hartmann, Arndt, Dimmler, Arno, Beckmann, Matthias W, Wachter, David L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262864/ https://www.ncbi.nlm.nih.gov/pubmed/22081974 http://dx.doi.org/10.1186/1471-2407-11-486

Ejemplares similares

Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
por: Schrauder, Michael G., et al.
Publicado: (2012)

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
por: Hein, Alexander, et al.
Publicado: (2014)

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
por: Gass, Paul, et al.
Publicado: (2018)

Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
por: Burghaus, Stefanie, et al.
Publicado: (2015)

Correlation of mammographic density and serum calcium levels in patients with primary breast cancer
por: Hack, Carolin C., et al.
Publicado: (2017)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound
por: Häberle, Lothar, et al.
Publicado: (2017)

Levels of uPA and PAI-1 in breast cancer and its correlation to Ki67-index and results of a 21-multigene-array
por: Völker, Hans-Ullrich, et al.
Publicado: (2018)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases
por: Lux, Michael P., et al.
Publicado: (2015)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Characterizing mammographic images by using generic texture features
por: Häberle, Lothar, et al.
Publicado: (2012)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
por: Wunderle, Marius, et al.
Publicado: (2020)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Mammographic density and prognosis in primary breast cancer patients
por: Heindl, Felix, et al.
Publicado: (2021)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
por: Wunderle, Marius, et al.
Publicado: (2018)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
por: Wachter, David L., et al.
Publicado: (2014)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

Ki-67 biomarker in breast cancer of Indian women
por: Patil, Amit V., et al.
Publicado: (2011)

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
por: Mesko, Shane, et al.
Publicado: (2013)

Ki-67 Expression in Hydatidiform Moles and Hydropic Abortions
por: Khooei, Alireza, et al.
Publicado: (2013)

Proliferating Trichilemmal Cyst: The Value Of Ki67 Immunostaining
por: Rangel-Gamboa, Lucia, et al.
Publicado: (2013)

The cell proliferation antigen Ki-67 organises heterochromatin
por: Sobecki, Michal, et al.
Publicado: (2016)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Immunohistochemical detection of Hsp90 and Ki-67 in pterygium
por: Sebastiá, Roberto, et al.
Publicado: (2013)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
por: Gupta, Amit, et al.
Publicado: (2021)

Chromosome clustering in mitosis by the nuclear protein Ki-67
por: Stamatiou, Konstantinos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kb5d1rr0b103lutf2pmtcs4j3p